EUVIMEDEUVIMED entdecken
Crossref

Lipophilic Salts of High Melting Point Drugs Modulate Solid-State Properties and Organic Solubility to Enable Manufacturability of Amorphous Solid Dispersions

Stella P. Petrova, Matthew M. Behymer, Naga K. Duggirala, Aaron Goodwin, Dana E. Moseson-Tarrh, Lynne S. Taylor

Organic Process Research & Development · 21.08.2026 · 30 (8) · 2179-2193

DOI: 10.1021/acs.oprd.6c00079 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Organic Process Research & Development, online erschienen am 06.08.2026. Verfasst von Stella P. Petrova und 5 weiteren Autor:innen. Die Arbeit nennt 76 Literaturangaben. Gefördert von: Pfizer.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amorphous solid dispersion (ASD) manufacturability is constrained by active pharmaceutical ingredient physicochemical properties; high melting point (Tm) and high glass transition temperature (Tg) limit hot-melt extrusion (HME), and low organic solubility limits spray-drying (SD) throughput. We evaluated lipophilic counterion choice as a solid-state design lever to enable ASD manufacturability by SD or HME. Nine lipophilic salts of atazanavir (ATZ) and mebendazole (MBZ) were prepared with sulfate and sulfonate counterions spanning a range of chain lengths and steric bulk, and characterized by 1H nuclear magnetic resonance spectroscopy, powder X-ray diffraction, differential scanning calorimetry, and polarized light microscopy. Lipophilic salts showed Tm and Tg reductions relative to their free base, with Tg reductions of up to approximately 30 °C. Organic solubility in ethanol, acetone, and tetrahydrofuran improved 2–15× or greater across most salt-solvent combinations. Vacuum compression molding confirmed that a representative lipophilic salt (ATZ-pTSA) enables thermal amorphization at HME-relevant processing temperatures, where the ATZ free base does not fully melt or dissolve into the model polymer. Counterion choice functions as a solid-state design lever for ASD manufacturability through a proposed lattice-packing disruption mechanism that simultaneously reduces Tm and Tg and improves organic solubility.

Förderung

  • Pfizer

Zitieren

APA

Petrova, S. P., Behymer, M. M., Duggirala, N. K., Goodwin, A., Moseson-Tarrh, D. E., & Taylor, L. S. (2026). Lipophilic Salts of High Melting Point Drugs Modulate Solid-State Properties and Organic Solubility to Enable Manufacturability of Amorphous Solid Dispersions. Organic Process Research & Development, 30(8), 2179-2193. https://doi.org/10.1021/acs.oprd.6c00079

Vancouver

Petrova SP, Behymer MM, Duggirala NK, Goodwin A, Moseson-Tarrh DE, Taylor LS. Lipophilic Salts of High Melting Point Drugs Modulate Solid-State Properties and Organic Solubility to Enable Manufacturability of Amorphous Solid Dispersions. Organic Process Research & Development. 2026;30(8):2179-2193. doi:10.1021/acs.oprd.6c00079

BibTeX
@article{Petrova2026,
  author = {Petrova, Stella P. and Behymer, Matthew M. and Duggirala, Naga K. and Goodwin, Aaron and Moseson-Tarrh, Dana E. and Taylor, Lynne S.},
  title = {Lipophilic Salts of High Melting Point Drugs Modulate Solid-State Properties and Organic Solubility to Enable Manufacturability of Amorphous Solid Dispersions},
  journal = {Organic Process Research & Development},
  year = {2026},
  volume = {30},
  number = {8},
  pages = {2179--2193},
  doi = {10.1021/acs.oprd.6c00079}
}
Kostenlos starten →